Jeffrey Berenberg, MD, MACP

Physician and Potter, Principal Investigator University of Hawaii NCORP, interested in healthcare literacy.

[Binaytara @binaytara]

Nurses and APPs are driving innovation where it’s needed most. Session 3B at #SCHD26 highlights oncology nursing and advanced practice–led models improving access, education, and continuity of care in underserved communities. This session showcases how frontline clinicians are advancing cancer equity through scalable solutions: https://t.co/dBi4fJiXcC

[Wendy Hensel @UHPresident]

Hawaii’s Sector Partnerships, a coalition of @cochawaii, the UH System, DBEDT, @kupuhawaii, @HealthcareHAH, and industry and community leaders, met to strengthen cross-sector alignment. Grateful for the shared vision to scale workforce development across our 10 campuses. Mahalo!

[Chalothorn “Sai” Wannaphut, MD @Sai_Wannaphut]

🌟Honored to receive the 2025 ASH Abstract Achievement Award! 🩸
🙏Grateful to @ASH_hematology for this recognition, and to my mentors, collaborators, and patients who inspire our work every day.
✨Excited to share our work at #ASH25 in Orlando this December!
🔗https://t.co/CPbzgUDoLV
#HemeTwitter #MedTwitter #Hematology #WomenInHematology #WomenInMedicine

[Nicole Grogan Fleege, MD @NicoleFleege]

@DrJoeUnger talks to us about the role of federal sponsorship in the design and conduct of cancer tx trials.

More likely to: focus on rare cancers and pediatric populations, study de-escalation strategies, & involve non-tx interventional trials.

➡️huge impact! #ASCOQLTY25

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

Phenomenal to close out #ASCOQLTY25 with a #liamSelfie. Liam the Llama is the @ASCO meeting mascot!

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

Funding cancer research from 4⃣diverse perspectives: a @ASCO #ASCOQLTY25 discussion featuring panelists:

🫶 Philanthropy/Development @DrKarenKnudsen
🧑‍💻 Start up @yzafar
👨‍🔬 Industry @NealMeropol
🌍 International @LGutnik

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

LAST @ASCO #ASCOQLTY25 panel!

Never Let a Crisis Go to Waste: Funding Cancer Research in a Time of Rapid Change
with panelists Drs @DrKarenKnudsen @yzafar @NealMeropol @LGutnik how can we sustain funding to continue to innovate & cure?

Moderators @DrLolaFayanju @chandlercortina

[Chalothorn “Sai” Wannaphut, MD @Sai_Wannaphut]

🏅 Honored to receive a 2025 Conquer Cancer Merit Award from @ConquerCancerFd @ASCO for our abstract on lung cancer disparities—selected for poster presentation at #ASCOQLTY25!
📌 Survival Disparities in NSCLC: Disaggregating Asians from NHPI in Hawaiʻi
🙏 Thank you to the #ASCOQuality team and our mentors at Hawai‘i Cancer Center. @UHCancerCenter
Looking forward to connecting with colleagues at the conference!
#NSCLC #Equity #SurvivalOutcome #Hawaii #OncTwitter #MedTwitter
@oncodaily @HemOncFellows @hemeoncfellow @IMG_Oncologists @OncoAlert

[Chalothorn “Sai” Wannaphut, MD @Sai_Wannaphut]

📢 Presenting our study at the ASCO Quality Care Symposium #ASCOQLTY25! @ASCO @ConquerCancerFd
🫁 NSCLC survival disparities revealed distinct outcomes among Asian & Native Hawaiian and Pacific Islander patients (NHPI)
🇨🇳 Chinese had the lowest risk of death (aHR 0.82, p =0.003, adjusted for treatment).
🏝️ NHPI had the highest risk (aHR 1.14, p = 0.016), likely driven by higher rates of underinsurance or lack of insurance, but the difference was no longer significant after adjusting for treatment.
➡️ Asian populations are not homogeneous.
📰 Now published in Cancer Epidemiology 🔗 https://t.co/dHNsh1nJpd
📍Poster G13 (Session B), 12:15 – 1:30 PM — looking forward to connecting!
#ASCO #MeritAward #OncoTwitter #HemeOnc #NSCLC #LCSM #CancerDisparities #HealthEquity #MedTwitter
@oncodaily @IMG_Oncologists @HemOncFellows @Lung_Cancers @MedicalwatchHQ @IASLC @LungAssociation @LungSummit

[Eric K. Singhi, MD @lungoncdoc]

At #ASCOQLTY25, Dr. @ipreeshagul shares our collaborative, patient-centered study tackling barriers to clinical trial enrollment, and, more importantly, the SOLUTIONS!

Listen here 👇🏽
@ASCO @MSKCancerCenter @lcrf_org

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Findings from the HN-STAR trial! Using an ePRO-informed clinical decision support tool enhanced discussions during follow-up visits for post-treatment head & neck cancer survivors @ASCO #ASCOQLTY25 #TaylaSalz

[Jeffrey Berenberg, MD, MACP @NCORPHawaiiDOC]

@crisbergerot @ASCO @UHCancerCenter @wakeforestmed #NCORP proud to have Queens Med Centrr in Hawaii one of our UH Hawai’i Consortium sites participate in this important study!!!

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Dr. @MBakitas highlights the evolving State of the Science in Palliative Care, showing how evidence-based models can transform patient and caregiver experiences. Inspiring work! 💙 @ASCO #ASCOQLTY25

[Jeffrey Berenberg, MD, MACP @NCORPHawaiiDOC]

@ASCO #ASCOQLTY25 @UHCancerCenter @wakeforestmed
Presenting our abstract on landscape survey capabilities: health literacy, language access and outreach in the NCORP. More needs to be done!

[Jeffrey Berenberg, MD, MACP @NCORPHawaiiDOC]

@ASCO #ASCOQLTY25 @UHCancerCenter #healthcareliteracy looking forward to our poster showing low rates of health literacy screening in the #NCORP and implications for cancer patients.

[Jeffrey Berenberg, MD, MACP @NCORPHawaiiDOC]

#ASCOQLTY25 @ASCO @UHCancerCenter Dr Jayden Gracie showed burden of prior authorizations. #Healthcare #insurance #cancercare

[Jeffrey Berenberg, MD, MACP @NCORPHawaiiDOC]

#ASCOQLTY25 @ASCO @UHCancerCenter Dr John Lin discussed Medicare changes impact on oral drug abandonment.

[Chalothorn “Sai” Wannaphut, MD @Sai_Wannaphut]

🤩 Excited to have received my #ASCOQLTY25 badge and 🎗️ @ConquerCancerFd Merit Award!
🌟Our study highlights survival outcomes among patients with non–small cell lung cancer, aiming to improve equity and quality in cancer care.
🤝Looking forward to presenting our work at the @ASCO Quality Care Symposium and connecting with colleagues.
#ASCO #OncoTwitter #LCSM #MedTwitter #HemeOnc #CancerCare
@IMG_Oncologists @oncodaily @HemOncFellows @HemOncWomenDocs @MedicalwatchHQ @LUNGevity @Lung_Cancers

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Deeply moved by Dr. @FayUCCancerCr @ASCO #ASCOQLTY25 talk on moral distress in shared decision-making. A truly essential conversation about the values that shape patient care.

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

🌟Incredible insights from Dr #MelisaWong on tough conversations and shared decisions @ASCO #ASCOQLTY25